RxSight (RXST) Non-Current Debt (2020 - 2023)
RxSight's (RXST) quarterly Non-Current Debt came in at $19.6 million in Q2 2023, down 50.88% YoY from $39.9 million in Q2 2022, and down 51.4% on a QoQ basis from $40.3 million in Q1 2023.
RxSight (RXST) Non-Current Debt (2020 - 2023) Analysis & Trends
RxSight (RXST) has 4 years of Non-Current Debt data on file, last reported at $19.6 million in Q2 2023.
- Quarterly Non-Current Debt fell 50.88% year-over-year to $19.6 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $19.6 million (down 50.88% YoY) and the FY2022 annual result came in at $40.2 million, up 1.03% from the prior year.
- Non-Current Debt retreated to $19.6 million in Q2 2023, from $40.3 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $40.3 million in Q1 2023 to a low of $19.6 million in Q2 2023.
- A 4-year average of $36.3 million and a median of $39.8 million in 2021 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2021 — Non-Current Debt soared 62.96% — and 2023, when it tumbled 50.88%.
- Tracing RXST's Non-Current Debt over 4 years: stood at $24.4 million in 2020, then soared by 62.96% to $39.8 million in 2021, then rose by 1.03% to $40.2 million in 2022, then slumped by 51.23% to $19.6 million in 2023.
- The last three Non-Current Debt figures came in at $19.6 million (Q2 2023), $40.3 million (Q1 2023), and $40.2 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 19.59 Mn |
| Mar 31, 2023 | 40.31 Mn |
| Dec 31, 2022 | 40.17 Mn |
| Sep 30, 2022 | 40.03 Mn |
| Jun 30, 2022 | 39.88 Mn |
| Mar 31, 2022 | 39.89 Mn |
| Dec 31, 2021 | 39.76 Mn |
| Sep 30, 2021 | 39.64 Mn |
| Jun 30, 2021 | 39.51 Mn |
| Dec 31, 2020 | 24.40 Mn |